Tourette Syndrome Treatment Global Market Report 2024

Description

Tourette syndrome treatment involves managing symptoms such as tics and behavioral issues through a variety of approaches, including medication, behavioral therapies, and supportive services. The goal is to decrease symptom frequency and severity while enhancing the overall quality of life for individuals with Tourette syndrome.

The main classes of drugs used in tourette syndrome treatment include antiadrenergic agents, antipsychotic agents, atypical antipsychotic agents, carbonic anhydrase inhibitors, anticonvulsants, and others. Antiadrenergic agents work by blocking or inhibiting the effects of adrenaline and noradrenaline. These medications are available through different channels such as hospital pharmacies, retail pharmacies, and online pharmacies, and are utilized in both pediatric and adult contexts.

The tourette syndrome treatment market research report is one of a series of new reports from The Business Research Company that provides tourette syndrome treatment market statistics, including tourette syndrome treatment industry global market size, regional shares, competitors with a tourette syndrome treatment market share, detailed tourette syndrome treatment market segments, market trends and opportunities, and any further data you may need to thrive in the tourette syndrome treatment industry. This tourette syndrome treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tourette syndrome treatment market size has grown strongly in recent years. It will grow from $2.23 billion in 2023 to $2.37 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The increase during the historic period can be attributed to advancements in pharmacotherapy, increased clinical research and understanding, the development of supportive therapies, enhancements in diagnosis and awareness, and the issuance of regulatory approvals and guidelines.

The tourette syndrome treatment market size is expected to see strong growth in the next few years. It will grow to $3.04 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The rise in the forecast period can be attributed to advancements in precision medicine, the expansion of telehealth services, the integration of digital health solutions, increased funding for research, and the growing popularity of complementary and alternative therapies. Major trends expected in this period include advances in gene therapy, broader access to care, non-pharmacological interventions, global collaborative initiatives, and the emergence of behavioral therapies.

The anticipated rise in healthcare spending is set to drive growth in the tourette syndrome treatment market. Healthcare spending encompasses all expenses on healthcare services and products, including treatments, medications, hospital stays, and preventive care, over a specific period, reflecting the overall healthcare costs within a population. This increase is fueled by the escalating costs of advanced medical technologies, aging populations, and the prevalence of chronic illnesses. In Tourette syndrome treatment, healthcare spending goes towards developing advanced diagnostic tools, medications, and behavioral therapies. It also supports ongoing research, patient education, and access to specialized care. For example, as reported by the National Institutes of Health in January 2024, healthcare spending in the US grew by 4.1% in 2022 to reach $4.5 trillion, marking a faster growth rate than the 3.2% increase seen in 2021. Consequently, the surge in healthcare spending is propelling the tourette syndrome treatment market forward.

Key players in the tourette syndrome treatment market are concentrating on creating cutting-edge products such as wearable neuromodulation devices to gain a competitive advantage. These devices are portable electronic tools designed to administer targeted electrical or magnetic stimulation to specific nerves or brain regions, modulating neural activity. They are commonly used to treat neurological disorders, manage pain, or enhance cognitive functions. For instance, in August 2021, Neurotherapeutics Solutions Ltd., a UK-based medical device company, introduced a wearable neuromodulation device tailored to alleviate tourette's syndrome symptoms. This stimulation aims to synchronize rhythmic electrical brain activity linked with movement suppression, ultimately decreasing tic frequency, intensity, and urge-to-tic in individuals with tourette syndrome.

In April 2022, Saladax Biomedical Inc., a US-based company specializing in therapeutic drug monitoring (TDM) assays, acquired a patent portfolio related to antipsychotic drug testing from Janssen Pharmaceutica NV. for an undisclosed sum. This acquisition positions Saladax Biomedical to potentially enhance diagnostic tests and treatment approaches for Tourette syndrome by leveraging Janssen Pharmaceutica's antipsychotic drug intellectual property. Janssen Pharmaceutica NV., based in Belgium, is a key player in manufacturing, marketing, and distributing antipsychotic drugs utilized in treating tourette syndrome.

Major companies operating in the tourette syndrome treatment market are F Hoffmann-La Roche AG, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Biogen Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co. Ltd., Amneal Pharmaceuticals, Mallinckrodt Pharmaceuticals, Neurocrine Biosciences, Sunovion Pharmaceuticals Inc., Supernus Pharmaceuticals, Lundbeck AS, Voyager Therapeutics Inc., NeuroSigma Inc.

North America was the largest region in the tourette syndrome treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tourette syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tourette syndrome treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tourette syndrome treatment market consists of revenues earned by entities by providing services, such as pharmacotherapy, behavioral therapies, neurostimulation techniques, and supportive services used during the process. The market value includes the value of related goods sold by the service provider or included within the service offering. The Tourette syndrome treatment market also includes sales of antipsychotics, wrist devices, and non-antipsychotic medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tourette Syndrome Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tourette syndrome treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tourette syndrome treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tourette syndrome treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Antiadrenergic Agents; Antipsychotic Agents; Atypical Antipsychotic Agents; Carbonic Anhydrase Inhibitor Anticonvulsants; Other Drug Classes
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Application: Children; Adult
Companies Mentioned: F Hoffmann-La Roche AG; AbbVie Inc.; Bayer AG; Sanofi S.A.; Bristol-Myers Squibb
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18253

1. Executive Summary

2. Tourette Syndrome Treatment Market Characteristics

3. Tourette Syndrome Treatment Market Trends And Strategies

4. Tourette Syndrome Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Tourette Syndrome Treatment Market Size and Growth

5.1. Global Tourette Syndrome Treatment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Tourette Syndrome Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Tourette Syndrome Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Tourette Syndrome Treatment Market Segmentation

6.1. Global Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Antiadrenergic Agents
Antipsychotic Agents
Atypical Antipsychotic Agents
Carbonic Anhydrase Inhibitor Anticonvulsants
Other Drug Classes
6.2. Global Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.3. Global Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Children
Adult

7. Tourette Syndrome Treatment Market Regional And Country Analysis

7.1. Global Tourette Syndrome Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Tourette Syndrome Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Tourette Syndrome Treatment Market

8.1. Asia-Pacific Tourette Syndrome Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Tourette Syndrome Treatment Market

9.1. China Tourette Syndrome Treatment Market Overview
9.2. China Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Tourette Syndrome Treatment Market

10.1. India Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Tourette Syndrome Treatment Market

11.1. Japan Tourette Syndrome Treatment Market Overview
11.2. Japan Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Tourette Syndrome Treatment Market

12.1. Australia Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Tourette Syndrome Treatment Market

13.1. Indonesia Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Tourette Syndrome Treatment Market

14.1. South Korea Tourette Syndrome Treatment Market Overview
14.2. South Korea Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Tourette Syndrome Treatment Market

15.1. Western Europe Tourette Syndrome Treatment Market Overview
15.2. Western Europe Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Tourette Syndrome Treatment Market

16.1. UK Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Tourette Syndrome Treatment Market

17.1. Germany Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Tourette Syndrome Treatment Market

18.1. France Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Tourette Syndrome Treatment Market

19.1. Italy Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Tourette Syndrome Treatment Market

20.1. Spain Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Tourette Syndrome Treatment Market

21.1. Eastern Europe Tourette Syndrome Treatment Market Overview
21.2. Eastern Europe Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Tourette Syndrome Treatment Market

22.1. Russia Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Tourette Syndrome Treatment Market

23.1. North America Tourette Syndrome Treatment Market Overview
23.2. North America Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Tourette Syndrome Treatment Market

24.1. USA Tourette Syndrome Treatment Market Overview
24.2. USA Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Tourette Syndrome Treatment Market

25.1. Canada Tourette Syndrome Treatment Market Overview
25.2. Canada Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Tourette Syndrome Treatment Market

26.1. South America Tourette Syndrome Treatment Market Overview
26.2. South America Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Tourette Syndrome Treatment Market

27.1. Brazil Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Tourette Syndrome Treatment Market

28.1. Middle East Tourette Syndrome Treatment Market Overview
28.2. Middle East Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Tourette Syndrome Treatment Market

29.1. Africa Tourette Syndrome Treatment Market Overview
29.2. Africa Tourette Syndrome Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Tourette Syndrome Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Tourette Syndrome Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Tourette Syndrome Treatment Market Competitive Landscape And Company Profiles

30.1. Tourette Syndrome Treatment Market Competitive Landscape
30.2. Tourette Syndrome Treatment Market Company Profiles
- 30.2.1. F Hoffmann-La Roche AG
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. AbbVie Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Bayer AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Sanofi S.A.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bristol-Myers Squibb
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Tourette Syndrome Treatment Market Other Major And Innovative Companies

31.1. AstraZeneca PLC
31.2. Novartis International AG
31.3. Takeda Pharmaceutical Company Limited
31.4. Eli Lilly and Company
31.5. Viatris Inc.
31.6. Otsuka Pharmaceutical Co. Ltd.
31.7. Biogen Inc.
31.8. Eisai Co. Ltd.
31.9. Jazz Pharmaceuticals plc
31.10. Mitsubishi Tanabe Pharma Corporation
31.11. Kyowa Kirin Co. Ltd.
31.12. Amneal Pharmaceuticals
31.13. Mallinckrodt Pharmaceuticals
31.14. Neurocrine Biosciences
31.15. Sunovion Pharmaceuticals Inc.

32. Global Tourette Syndrome Treatment Market Competitive Benchmarking

33. Global Tourette Syndrome Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Tourette Syndrome Treatment Market

35. Tourette Syndrome Treatment Market Future Outlook and Potential Analysis

35.1 Tourette Syndrome Treatment Market In 2028 - Countries Offering Most New Opportunities
35.2 Tourette Syndrome Treatment Market In 2028 - Segments Offering Most New Opportunities
35.3 Tourette Syndrome Treatment Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer